CHICAGO, October 08, 2025--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered ...
VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...
CHICAGO--(BUSINESS WIRE)--#BioTechNews--VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
Asianet Newsable on MSN
GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?
Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE.
Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector system will be used, with AAV and lentivirus being two of the most commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback